# Alerus Financial Corp: financial statements, quarterly

ALRS · Nasdaq · CIK 903419 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/alrs.md) · [Financials](/companies/alrs/financials.md) · [Filings](/companies/alrs/filings.md) · [Insiders](/companies/alrs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/alrs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [21.6](/filings/0001558370-23-017441.md) | [23.1 d](/filings/0001558370-24-002829.md) | [26.8](/filings/0001558370-24-006547.md) | [29.0](/filings/0001558370-24-011623.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.4](/filings/0001437749-24-032818.md) | [(3.1) d](/filings/0001437749-26-006820.md) | [2.1](/filings/0001437749-25-014641.md) | [1.9](/filings/0001437749-25-024880.md) | [1.6](/filings/0001437749-25-033350.md) | [(0.2) d](/filings/0001437749-26-006820.md) | [4.2](/filings/0001437749-26-014481.md) | [6.1](/filings/0001437749-26-025463.md) | [5.1](/filings/0001437749-25-033350.md) | [(10.3) d](/filings/0001437749-26-006820.md) | [7.3](/filings/0001437749-26-014481.md) | [6.4](/filings/0001437749-26-025463.md) |
| Net income | $m | [9.2](/filings/0001437749-24-032818.md) | [(14.8) d](/filings/0001437749-26-006820.md) | [6.4](/filings/0001437749-25-014641.md) | [6.2](/filings/0001437749-25-024880.md) | [5.2](/filings/0001437749-25-033350.md) | [(0.1) d](/filings/0001437749-26-006820.md) | [13.3](/filings/0001437749-26-014481.md) | [20.3](/filings/0001437749-26-025463.md) | [16.9](/filings/0001437749-25-033350.md) | [(33.1) d](/filings/0001437749-26-006820.md) | [23.0](/filings/0001437749-26-014481.md) | [20.9](/filings/0001437749-26-025463.md) |
| Diluted EPS | $ per share | [0.45](/filings/0001437749-24-032818.md) | not reported | [0.32](/filings/0001437749-25-014641.md) | [0.31](/filings/0001437749-25-024880.md) | [0.26](/filings/0001437749-25-033350.md) | not reported | [0.52](/filings/0001437749-26-014481.md) | [0.78](/filings/0001437749-26-025463.md) | [0.65](/filings/0001437749-25-033350.md) | not reported | [0.89](/filings/0001437749-26-014481.md) | [0.81](/filings/0001437749-26-025463.md) |
| Basic EPS | $ per share | [0.46](/filings/0001437749-24-032818.md) | not reported | [0.32](/filings/0001437749-25-014641.md) | [0.31](/filings/0001437749-25-024880.md) | [0.26](/filings/0001437749-25-033350.md) | not reported | [0.52](/filings/0001437749-26-014481.md) | [0.79](/filings/0001437749-26-025463.md) | [0.66](/filings/0001437749-25-033350.md) | not reported | [0.90](/filings/0001437749-26-014481.md) | [0.82](/filings/0001437749-26-025463.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [64.7](/filings/0001558370-23-017441.md) | [130](/filings/0001437749-25-007629.md) | [546](/filings/0001558370-24-006547.md) | [438](/filings/0001558370-24-011623.md) | [66.0](/filings/0001437749-24-032818.md) | [61.2](/filings/0001437749-26-006820.md) | [83.0](/filings/0001437749-25-014641.md) | [80.9](/filings/0001437749-25-024880.md) | [92.0](/filings/0001437749-25-033350.md) | [67.2](/filings/0001437749-26-025463.md) | [129](/filings/0001437749-26-014481.md) | [109](/filings/0001437749-26-025463.md) |
| Total assets | $m | [3,833](/filings/0001437749-24-032818.md) | [3,908](/filings/0001437749-26-006820.md) | [4,338](/filings/0001437749-25-014641.md) | [4,359](/filings/0001437749-25-024880.md) | [4,359](/filings/0001437749-25-033350.md) | [5,262](/filings/0001437749-26-006820.md) | [5,340](/filings/0001437749-26-014481.md) | [5,324](/filings/0001437749-26-025463.md) | [5,331](/filings/0001437749-25-033350.md) | [5,230](/filings/0001437749-26-025463.md) | [5,288](/filings/0001437749-26-014481.md) | [5,289](/filings/0001437749-26-025463.md) |
| Total liabilities | $m | [3,520](/filings/0001558370-23-017441.md) | [3,539](/filings/0001437749-25-007629.md) | [3,966](/filings/0001558370-24-006547.md) | [3,985](/filings/0001558370-24-011623.md) | [3,698](/filings/0001437749-24-032818.md) | [4,766](/filings/0001437749-26-006820.md) | [4,825](/filings/0001437749-25-014641.md) | [4,791](/filings/0001437749-25-024880.md) | [4,780](/filings/0001437749-25-033350.md) | [4,665](/filings/0001437749-26-025463.md) | [4,713](/filings/0001437749-26-014481.md) | [4,706](/filings/0001437749-26-025463.md) |
| Long-term debt | $m | [58.9](/filings/0001558370-23-017441.md) | [59.0](/filings/0001437749-25-007629.md) | [59.0](/filings/0001558370-24-006547.md) | [59.0](/filings/0001558370-24-011623.md) | [59.0](/filings/0001437749-24-032818.md) | [59.1](/filings/0001437749-26-006820.md) | [59.1](/filings/0001437749-25-014641.md) | [59.1](/filings/0001437749-25-024880.md) | [59.2](/filings/0001437749-25-033350.md) | [59.2](/filings/0001437749-26-025463.md) | [59.2](/filings/0001437749-26-014481.md) | [59.2](/filings/0001437749-26-025463.md) |
| Short-term borrowings | $m | [515](/filings/0001558370-23-017441.md) | [314](/filings/0001437749-25-007629.md) | [555](/filings/0001558370-24-006547.md) | [555](/filings/0001558370-24-011623.md) | [245](/filings/0001437749-24-032818.md) | [239](/filings/0001437749-26-006820.md) | [200](/filings/0001437749-25-014641.md) | [315](/filings/0001437749-25-024880.md) | [200](/filings/0001437749-25-033350.md) | [309](/filings/0001437749-26-025463.md) | [200](/filings/0001437749-26-014481.md) | [345](/filings/0001437749-26-025463.md) |
| Shareholders' equity | $m | [349](/filings/0001437749-24-032818.md) | [369](/filings/0001437749-26-006820.md) | [372](/filings/0001437749-25-024880.md) | [373](/filings/0001437749-25-033350.md) | [386](/filings/0001437749-25-033350.md) | [495](/filings/0001437749-26-025463.md) | [514](/filings/0001437749-26-025463.md) | [533](/filings/0001437749-26-025463.md) | [551](/filings/0001437749-25-033350.md) | [565](/filings/0001437749-26-025463.md) | [575](/filings/0001437749-26-014481.md) | [583](/filings/0001437749-26-025463.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.8 d](/filings/0001437749-24-032818.md) | [2.0 d](/filings/0001437749-26-006820.md) | [11.7](/filings/0001437749-25-014641.md) | [(12.5) d](/filings/0001437749-25-024880.md) | [20.2 d](/filings/0001437749-25-033350.md) | [2.3 d](/filings/0001437749-26-006820.md) | [7.7](/filings/0001437749-26-014481.md) | [10.7 d](/filings/0001437749-26-025463.md) | [32.8 d](/filings/0001437749-25-033350.md) | [16.3 d](/filings/0001437749-26-006820.md) | [27.8](/filings/0001437749-26-014481.md) | [18.6 d](/filings/0001437749-26-025463.md) |
| Capital expenditure | $m | [0.4 d](/filings/0001437749-24-032818.md) | [1.6 d](/filings/0001437749-26-006820.md) | [0.9](/filings/0001437749-25-014641.md) | [3.7 d](/filings/0001437749-25-024880.md) | [2.8 d](/filings/0001437749-25-033350.md) | [5.0 d](/filings/0001437749-26-006820.md) | [2.1](/filings/0001437749-26-014481.md) | [3.1 d](/filings/0001437749-26-025463.md) | [2.5 d](/filings/0001437749-25-033350.md) | [1.0 d](/filings/0001437749-26-006820.md) | [2.0](/filings/0001437749-26-014481.md) | [0.7 d](/filings/0001437749-26-025463.md) |
| Dividends paid | $m | [3.6 d](/filings/0001437749-24-032818.md) | [3.8 d](/filings/0001437749-26-006820.md) | [3.8](/filings/0001437749-25-014641.md) | [3.8 d](/filings/0001437749-25-024880.md) | [4.0 d](/filings/0001437749-25-033350.md) | [4.0 d](/filings/0001437749-26-006820.md) | [5.1](/filings/0001437749-26-014481.md) | [5.3 d](/filings/0001437749-26-025463.md) | [5.3 d](/filings/0001437749-25-033350.md) | [5.1 d](/filings/0001437749-26-006820.md) | [5.1](/filings/0001437749-26-014481.md) | [5.6 d](/filings/0001437749-26-025463.md) |
| Share repurchases | $m | [1.2 d](/filings/0001437749-24-032818.md) | [2.1 d](/filings/0001437749-26-006820.md) | [0.2](/filings/0001437749-25-014641.md) | [0.0 d](/filings/0001437749-25-024880.md) | [0.1 d](/filings/0001437749-25-033350.md) | [0.0 d](/filings/0001437749-26-006820.md) | [0.1](/filings/0001437749-26-014481.md) | [0.0 d](/filings/0001437749-26-025463.md) | [0.3 d](/filings/0001437749-25-033350.md) | [0.2 d](/filings/0001437749-26-006820.md) | [6.5](/filings/0001437749-26-014481.md) | [7.1 d](/filings/0001437749-26-025463.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [20.2](/filings/0001558370-23-017441.md) | [20.2](/filings/0001558370-24-006547.md) | [20.2](/filings/0001558370-24-011623.md) | [20.1](/filings/0001437749-24-032818.md) | [20.0](/filings/0001437749-25-014641.md) | [20.1](/filings/0001437749-25-024880.md) | [20.1](/filings/0001437749-25-033350.md) | [25.7](/filings/0001437749-26-014481.md) | [25.7](/filings/0001437749-26-025463.md) | [25.7](/filings/0001437749-25-033350.md) | [25.7](/filings/0001437749-26-014481.md) | [25.4](/filings/0001437749-26-025463.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 24,903,238 at 2026-07-30, from the cover of the [10-Q filed 2026-08-03](/filings/0001437749-26-025463.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.